Sana (SANA) EVP Dhavalkumar Patel Converts RSUs; 41,158 Shares Withheld

What Happened
Dhavalkumar D. Patel, EVP and Chief Scientific Officer of Sana Biotechnology (SANA), had 125,000 restricted stock units convert to common shares on August 26, 2026 (reported as an exercise/conversion of a derivative, code M, $0.00 per share). To satisfy tax withholding, 41,158 of those shares were surrendered/disposed on August 27, 2026 at an indicated value of $4.11 per share, totaling approximately $169,159 (code F).

Key Details

• Transaction dates and codes:
  • 2026-08-26: Conversion/exercise of derivative (RSU vesting) — 125,000 shares acquired, $0.00 per share (code M).
  • 2026-08-27: Shares withheld to cover tax liability — 41,158 shares disposed at $4.11 per share, total ≈ $169,159 (code F).
• Shares owned after the transactions: not stated in the provided filing excerpt.
• Footnotes:
  • F1: Each restricted stock unit (RSU) represents a contingent right to receive one share of Sana common stock.
  • F2: Vesting schedule — 25% vested Aug 26, 2025 and Aug 26, 2026; remaining RSUs vest in two equal installments on Aug 26, 2027 and Aug 26, 2028, subject to continued service.
• Filing timeliness: no late-filing indication in the provided data.

Context

• This was a routine RSU vesting and tax-withholding event (shares surrendered to cover taxes), not an open-market sale. That means the disposal of 41,158 shares reflects tax withholding rather than a directional sell decision by the insider.
• The conversion was recorded at $0.00 per share because RSUs convert to shares rather than requiring a cash exercise price.